• 1. An astrophysically-relevant mechanism for amino acid enantiomer enrichment
  Stephen P. Fletcher,Richard B. C. Jagt,Ben L. Feringa Chem. Commun., 2007, 2578-2580
• 2. An atlas of endohedral Sc2S cluster fullerenes?
  Li-Hua Gan,Rui Wu,Jian-Lei Tian,Patrick W. Fowler Phys. Chem. Chem. Phys., 2017,19, 419-425
• 3. An approach to 7-aza-1-phosphanorbornane complexes: strain promoted rearrangement of 1-iminylphosphirane complexes and cycloaddition with olefins?
  Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526
• 4. An apparatus for determining small amounts of alchohol in sour milk and urine
  Analyst, 1964,89, 272-275
• 5. An amorphous lanthanum–iridium solid solution with an open structure for efficient water splitting?
  Wei Sun,Chenglong Ma,Xinlong Tian,Jianjun Liao,Ji Yang,Chengjun Ge,Weiwei Huang J. Mater. Chem. A, 2020,8, 12518-12525

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Acetanilides
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Anilides Acetanilides
• Pharmaceutical and Biochemical Products Medicinal Building Blocks Fluorine containing Building Blocks

Professional Introduction to 2',4'-Difluoroacetanilide (CAS No. 399-36-0)

2',4'-Difluoroacetanilide, identified by the Chemical Abstracts Service registry number 399-36-0, is a fluorinated aromatic amide with significant applications in the field of pharmaceutical chemistry and agrochemical research. This compound, characterized by its dual fluorine substitutions at the 2' and 4' positions of the acetanilide backbone, exhibits unique structural and electronic properties that make it a valuable intermediate in synthetic chemistry. The presence of fluorine atoms enhances the lipophilicity and metabolic stability of molecules derived from this scaffold, making it particularly relevant in drug discovery programs targeting a wide range of therapeutic areas.

The synthesis of 2',4'-Difluoroacetanilide typically involves the condensation of 2,4-difluoroacetic acid with aniline under controlled conditions, often catalyzed by acidic or basic reagents. The reaction proceeds via an amide bond formation, yielding the desired product with high regioselectivity due to the electron-withdrawing effect of the fluorine substituents. Advanced synthetic methodologies, such as transition-metal-catalyzed cross-coupling reactions, have also been explored to introduce additional functional groups or to modify the core structure for tailored biological activities.

In recent years, 2',4'-Difluoroacetanilide has garnered attention in medicinal chemistry for its role as a key building block in the development of novel therapeutic agents. Its structural motif is found in several lead compounds that have advanced into clinical trials for diseases such as cancer, infectious disorders, and inflammatory conditions. The fluorine atoms contribute to the compound's binding affinity by modulating hydrogen bonding interactions and hydrophobicity, thereby improving pharmacokinetic profiles. Furthermore, computational studies have demonstrated that the electron density distribution around the fluoro-substituted aromatic ring can be fine-tuned to enhance target receptor interactions.

One of the most compelling applications of 2',4'-Difluoroacetanilide is in the synthesis of kinase inhibitors, where its scaffold provides a balance between molecular flexibility and rigidity required for effective enzyme inhibition. For instance, derivatives of this compound have shown promise in targeting tyrosine kinases implicated in oncogenesis. The fluorine atoms at the 2' and 4' positions play a critical role in stabilizing the transition state during enzyme-substrate complex formation, thereby increasing inhibitory potency. Structural-activity relationship (SAR) studies have highlighted that subtle modifications around the acetanilide core can significantly alter binding affinities and selectivity profiles.

Recent advancements in fluorinated heterocycles have further expanded the utility of 2',4'-Difluoroacetanilide beyond traditional pharmaceutical applications. Researchers have explored its incorporation into nucleoside analogs and antiviral agents, where fluorine substitution enhances viral polymerase inhibition. Additionally, agrochemical formulations leveraging this compound have demonstrated improved pest resistance and environmental compatibility due to altered metabolic pathways in target organisms. The versatility of CAS No. 399-36-0 underscores its importance as a versatile chemical entity with broad industrial relevance.

The analytical characterization of 2',4'-Difluoroacetanilide is typically performed using high-resolution spectroscopic techniques such as nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS). Proton NMR spectra exhibit characteristic chemical shifts for aromatic protons and amide protons, while carbon NMR provides detailed information about fluorine-containing carbons. X-ray crystallography has been employed to elucidate molecular conformations and intermolecular interactions, confirming the structural integrity of synthesized derivatives.

From a regulatory perspective, CAS No. 399-36-0 is subject to standard chemical safety protocols to ensure handling precautions are followed during laboratory-scale and industrial-scale production. While not classified as a hazardous material under current regulations, proper storage conditions are recommended to prevent degradation due to moisture or heat exposure. Manufacturers adhering to Good Manufacturing Practices (GMP) utilize controlled environments to maintain product purity and consistency across batches.

The future direction of research involving 2',4'-Difluoroacetanilide is likely to focus on expanding its synthetic methodologies through green chemistry approaches and exploring novel bioconjugation strategies for targeted drug delivery systems. Innovations in flow chemistry may enable scalable production processes with reduced waste generation, aligning with sustainable development goals in pharmaceutical manufacturing. Collaborative efforts between academia and industry are expected to drive discoveries that harness the full potential of this versatile intermediate.

In conclusion,2',4'-Difluoroacetanilide (CAS No. 399-36-0) represents a cornerstone compound in modern medicinal chemistry with far-reaching implications across multiple disciplines. Its unique structural features continue to inspire new synthetic pathways and therapeutic applications, solidifying its position as an indispensable tool for chemists engaged in drug discovery and material science research.

• 399-31-5(2'-Fluoroacetanilide)
• 3896-29-5(2',6'-Difluoroacetanilide)
• 398-90-3(N-(2,5-Difluorophenyl)acetamide)
• 1766-14-9(N-(2,3,5,6-Tetrafluorophenyl)acetamide)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)